Evidence map›Paper›PMID 27480425›Full record

ArticleZhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology2016

[Why dentists need to learn the epidemiological status and prevention strategy of coronary heart disease in China].

D Zhao

2 registry-linked trialsAbstract readEditorial
PubMed Publisher
In one paragraph

Article in Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03072082 phase4unknown statusstarted 2017, after this paper: background citation

Study of Curative Effect Evaluation of DanLou Tablet on Coronary Artery Disease Not Amenable to Revascularization on the Basis of Western Medicine Therapy

Ran2017Enrolled440Registered outcomes6Posted comparisons0ConditionsCoronary Artery Disease(CAD)ArmsAspirin Enteric-coated Tablets, Atorvastatin calcium, Clopidogrel Hydrogen Sulfate 75 MG Oral Tablet, Danlou Tablet, DanLou Tablet placebo
PMID 23173251PMID 20432394PMID 20531008PMID 20681275PMID 22019563PMID 23303884PMID 26142341PMID 27491230PMID 27847338other papers from this trial
Open the trial in the graph
NCT03072121 phase4unknown statusstarted 2017, after this paper: background citation

Study of Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization on the Basis of Western Medicine Therapy

Ran2017Enrolled440Registered outcomes6Posted comparisons0ConditionsCoronary Artery Disease(CAD)ArmsAspirin Enteric-coated Tablets, Atorvastatin calcium, Clopidogrel Hydrogen Sulfate 75 MG Oral Tablet, Isosorbide Mononitrate Tab 20 MG, Metoprolol Tartrate Tab 25 MG
PMID 27847338PMID 20432394PMID 20531008PMID 20681275PMID 22019563PMID 23303884other papers from this trial
Open the trial in the graph
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

D ZhaoBeijing Anzhen Hospital, Capital Medical University & Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing 100029, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronary heart disease(CHD) is the leading cause of death among 235 causes of death in human currently and kills more than 7 million peoples annually worldwide and will continuously be ranked as the top cause of death in next 20 years according the prediction. As the population aging and epidemics of major risk factors of CHD, there are remarkable raising incidence and mortality of CHD in Chinese population with increasing numbers of CHD patients. The CHD patients may visit dental clinics to seek help because of their oral or dental diseases. Some of those CHD patients may not be even aware of that they have CHD or the severity of their disease, and some of them may not know well for the medications they are taking. All of those situations may increase the risk of acute CHD event or other complications during clinical processes either for diagnosis or treatment in dental clinics. Therefore, it is important for dentists to learn basic knowledge of CHD including epidemiology and clinical characteristics and treatments of CHD.

Indexed as

DentistsHealth Knowledge, Attitudes, PracticeChinaCoronary DiseaseHumansIncidenceRisk Factors

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.